Lexicon Pharmaceuticals | LXRX - 资产





资产 更改 日
Abbott USD 110.43B 23.72B 2026-03
Acadia Pharmaceuticals USD 1.61B 41.04M 2026-03
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Akebia Therapeutics USD 362.52M 14.04M 2026-03
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Coherus Biosciences USD 258.34M 258.18M 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Halozyme Therapeutics USD 2.67B 147.4M 2026-03
Illumina USD 6.56B 85M 2026-03
Insmed USD 2.08B 188.7M 2026-03
Ironwood Pharmaceuticals USD 434.57M 37.66M 2026-03
J&J USD 201.06B 167M 2026-06
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
MacroGenics USD 217.87M 38.97M 2026-03
MannKind USD 744.4M 47.78M 2026-03
Merck USD 128.68B 8.18B 2026-03
Moderna USD 11.49B 850M 2026-03
Novartis USD 122.03B 3.5B 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Puma Biotechnology USD 202.86M 7.95M 2025-09
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Ultragenyx Pharmaceutical USD 1.3B 236M 2026-03
United Therapeutics USD 6.71B 1.17B 2026-03
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12